Jimeno Ruiz, S.; Peláez, A.; Labourt, A.; Acuña, F.M.; Linares, L.; Llana Martín, I.; Calle Gómez, Á.; Martínez, S.N.
Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain. Vaccines 2024, 12, 1160.
https://doi.org/10.3390/vaccines12101160
AMA Style
Jimeno Ruiz S, Peláez A, Labourt A, Acuña FM, Linares L, Llana Martín I, Calle Gómez Á, Martínez SN.
Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain. Vaccines. 2024; 12(10):1160.
https://doi.org/10.3390/vaccines12101160
Chicago/Turabian Style
Jimeno Ruiz, Sara, Adrián Peláez, Agustín Labourt, Florencia Mercedes Acuña, Lucía Linares, Isabel Llana Martín, Ángeles Calle Gómez, and Silvina Natalini Martínez.
2024. "Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain" Vaccines 12, no. 10: 1160.
https://doi.org/10.3390/vaccines12101160
APA Style
Jimeno Ruiz, S., Peláez, A., Labourt, A., Acuña, F. M., Linares, L., Llana Martín, I., Calle Gómez, Á., & Martínez, S. N.
(2024). Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain. Vaccines, 12(10), 1160.
https://doi.org/10.3390/vaccines12101160
